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OBJECTIVE — We previously demonstrated a positive association between chronic aerobic
exercise and dorsal foot skin blood flow during local heating in type 2 diabetic individuals. Thus,
we hypothesized that a prior acute bout of maximal exercise would also have positive effects on
postexercise blood flow.
RESEARCH DESIGN AND METHODS — Subjects consisted of 32 individuals with
type 2 diabetes and 26 nondiabetic control subjects further subdivided based on their physical
activity status: diabetic exerciser (DE), diabetic sedentary (DS), control exerciser (CE), or control
sedentary. Dorsal foot cutaneous blood flow was measured noninvasively by continuous laser-
Doppler assessment at baseline and during local heating to 44°C before and after a maximal bout
of cycle exercise. Interstitial nitric oxide (NO) levels were measured concurrently in the foot
dorsum.
RESULTS — Increases in blood flow and its responsiveness to local heating to 44°C were
significantly lower in both diabetic groups compared with CE before maximal exercise, but
perfusion responsiveness remained lower in DS subjects only after exercise (P  0.05). Baseline
skin blood flow was not different among groups preexercise, but it was significantly increased
postexercise in DE subjects only. Interstitial NO levels were not significantly different at either
time. At baseline, groups differed only in HbA1c, fasting serum glucose, HDL cholesterol, and
insulin resistance (homeostasis model assessment method).
CONCLUSIONS — All diabetic individuals exhibit a blunted responsiveness of cutaneous
blood flow with local heating to 44°C before maximal exercise compared with active nondiabetic
individuals, but after an exercise bout, it remains significantly blunted only in diabetic individ-
uals who are sedentary. These findings occur independently of changes in interstitial NO levels.
Diabetes Care 26:1883–1888, 2003
Skin blood flow is crucial to main-taining the flow of nutrients, regu-lating body temperature, and
healing cutaneal injuries, but its regula-
tion is undeniably complex. Humoral and
neurogenic factors affect flow; the more
potent vasodilators are nitric oxide (NO),
prostacyclin, and bradykinin, whereas va-
soconstrictors are angiotensin, endothe-
lin, and norepinephrine (1–3). Cutane-
ous vasodilation in the foot dorsum is
primarily dependent on neurogenic fac-
tors, small C-fiber nociceptors, which ac-
count for at least 75% of vasodilation
during heating (4).
An increased shunting of blood flow
away from skin may exist in the diabetic
state, likely caused by the loss of neural
control over the arteriovenous shunts ac-
tive in thermoregulation, creating a deficit
in cutaneous capillary blood flow (5–7).
Along with neural impairment, attenu-
ated NO-mediated forearm skin vasodila-
tion has been reported in type 2 diabetes
(8). Other studies suggest that such a de-
fect may be the result of an imbalance
among NO, vasodilator neuropeptides,
and vasoconstrictors (9).
At rest and during exercise, endothe-
lial-derived NO plays a role in matching
blood flow to tissue metabolism (10). In
nondiabetic subjects, chronic physical
activities have been demonstrated to in-
crease NO metabolism (11). Furthermore,
hyperglycemia in poorly controlled dia-
betes may reduce NO synthesis or quench
available NO (12), and vasodilation in
type 2 diabetic subjects with an attenu-
ated response to NO donors is impaired
(13).
In a cross-sectional study, we previ-
ously demonstrated lower skin perfusion
during heating in the dorsal foot in sed-
entary type 2 diabetic individuals (14).
This defect was present despite normal
increases in NO, suggesting that either
NO is not the main effector or a decrease
in its effectiveness played a role in the de-
fect (15). If NO effectiveness can possibly
be increased with exercise, then physical
activity may be beneficial in preventing or
reducing some of the impairment of vas-
cular endothelial function prevalent in di-
abetes (13).
To our knowledge, no studies have
examined the effects of prior maximal ex-
ercise on postexercise cutaneous blood
flow and NO. The purpose of this study,
therefore, was to examine the acute effect
of a single prior bout of maximal cycle
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exercise on dorsal foot blood flow and in-
terstitial NO levels immediately after the
activity during baseline conditions and
local heating to 44°C.
RESEARCH DESIGN AND
METHODS — We recruited diabetic
and nondiabetic subjects of both sexes
free of known cardiovascular disease, se-
vere peripheral neuropathy, unstable pro-
liferative retinopathy, end-stage renal
disease, uncontrolled hypertension, and
use of angiotensin II receptor blockers or
ACE inhibitors (known to enhance nerve
blood flow) (16). Eligible subjects gave
their written informed consent before
any testing. During the study, subjects
continued to take all of their normal
medications.
Diabetic and control subjects were
separated into four groups: control exer-
ciser (CE; n  13), control sedentary (CS;
n  13), diabetic exerciser (DE; n  15),
or diabetic sedentary (DS; n  17). Exer-
cisers had reportedly performed aerobic
activities three or more times per week at
least 30 min per session at moderate or
higher intensity for at least 6 months. The
sedentary individuals did very little regu-
lar exercise.
At the first visit, each subject under-
went a complete history and physical
examination. Percent body fat was esti-
mated using skinfold measurements at
three standardized sites. Standard fasting
laboratory blood work was performed.
Neuropathies were assessed using quan-
titative sensory testing—including vibra-
tion, pressure, cold and warm thermal,
and cold- and heat-induced pain thresh-
olds at the great toe—and assessment of
autonomic function, with measures of
cardiac variation with respiration (17).
Cutaneous blood flow
Dorsal foot skin blood flow was measured
noninvasively on both feet during se-
quential stimuli using continuous laser
Doppler assessment (18,19) before and
after acute exercise. After baseline flow
was assessed, a blood pressure cuff on the
subject’s calf was used to induce ischemia
reperfusion (IRP), followed by immersion
of the contralateral hand in ice water for
30 s (cold pressor). Finally, a small area of
skin (2 cm diameter) on the dorsum of
each foot was heated to 32°C for 5 min
and then to 44°C for 10 min to induce
neurogenic vasodilation (3,14). Postexer-
cise measurements were begun within 10
min of the completion of exercise.
Interstitial NO levels
We conducted real-time measurement of
cutaneous interstitial NO in vivo during
the blood flow testing as previously de-
scribed (14,20). In brief, a subcutaneous
microsensor was placed to sample circu-
lating cutaneal interstitial fluids, removed
during exercise, and then reinserted in
the contralateral foot postexercise. We
attempted to control for any artifac-
tual, heat-related changes in NO by fully
equilibrating the sensor at each new
temperature.
Maximal cycle ergometry exercise
Each subject then performed a graded
maximal protocol on a cycle ergometer
(Monark 828e) at a cadence of 50 rpm.
Subjects began at an external power out-
put of 0 and 20 watts for female and male
subjects, respectively, increasing by 20
watts every 3 min until volitional test ter-
mination. An online open indirect calo-
rimetry system (K4b2 System) measured
oxygen uptake and respiratory exchange
ratio during testing; peak oxygen con-
sumption (VO2peak) was determined as the
highest oxygen uptake averaged over 30 s.
Glucose and lactate values were measured
with a glucose/lactate analyzer (YSI 2300;
YSI, Yellow Springs, OH) using finger-
stick whole-blood samples obtained dur-
ing the final minute of each exercise stage.
Statistical analyses
ANOVAs were used to compare the group
means on various measures, and repeated
measures were used to compare results
from before and after maximal exercise,
with Tukey-Kramer post hoc analyses
where appropriate. Pearson product-
moment correlational analysis was also
used to examine associations between se-
lected measured variables. Significance
was set at P  0.05.
RESULTS — Resting subject charac-
teristics are given in Table 1. Subjects
differed by group on measures of fasting
serum glucose, HbA1c, fasting insulin lev-
els, insulin resistance (homeostasis model
assessment [HOMA] method) (21), and
HDL cholesterol. Significant differences
also existed in one measure of autonomic
function (Valsalva index), which was
higher (mean  SE) only in the combined
exercise groups (1.62  0.47) compared
with all sedentary subjects (1.45  0.45,
P  0.05). In sensory measures, heat pain
in the great toe was significantly different
between control subjects and the com-
bined diabetic groups (16.79  0.52 and
15.10  0.57°C, respectively), but no dif-
ferences existed in other sensory mea-
sures (data not shown).
In Table 2, the subjects’ responses to
maximal cycle ergometry work are
shown. Subject groups were comparable
in all variables, with the exception of
Table 1—Resting subject characteristics
CE CS DE DS
n (M/F) 13 (6/7) 13 (6/7) 15 (8/7) 17 (8/9)
Age (years) 57.5  2.5 56.2  2.6 54.4  2.5 56.0  2.1
Height (cm) 171.6  2.8 172.0  3.3 169.6  3.0 169.2  2.0
Weight (kg) 82.2  4.8 90.6  3.6 92.6  3.3 89.4  4.3
BMI (kg/m2) 27.8  1.3 30.9  1.7 32.6  1.7 31.2  1.5
Body fat (%) 28.2  2.5 31.7  2.0 30.0  2.0 29.7  2.1
SBP (mmHg) 131  4 137  4 136  3 141  4
DBP (mmHg) 81  2 86  3 85  2 85  2
Glucose (mmol/l) 5.0  0.1 5.1  0.1 6.5  0.3*† 7.4  0.6*†
HbA1c (%) 5.7  0.1 5.7  0.1 6.7  0.1*† 6.9  0.3*†
Insulin (U/ml) 7.3  0.8 9.8  1.5 13.9  1.9* 13.3  2.2*
Insulin resistance 2.0  0.2 2.6  0.5 4.8  0.6* 5.3  1.0*†
Cholesterol (mmol/l) 5.28  0.19 4.90  0.27 4.98  0.19 5.24  0.23
HDL-C (mmol/l) 1.85  0.15 1.41  0.10* 1.43  0.11* 1.42  0.09*
LDL-C (mmol/l) 2.89  0.16 2.78  0.19 2.79  0.15 3.03  0.20
Triglyceride (mmol/l) 1.14  0.19 1.49  0.26 1.63  0.22 1.69  0.26
Data are means  SE. Insulin resistance was determined by HOMA method (21) using fasting plasma insulin
and glucose values. *P  0.05 vs. CE; †P  0.05 vs. CS. DBP, diastolic blood pressure; HDL-C, HDL
cholesterol, LDL-C, LDL cholesterol; SBP, systolic blood pressure.
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postexercise insulin resistance, which was
significantly higher in both diabetic
groups than in either control group.
Table 3 shows the measured dorsal
foot skin blood flow in the nonprobed
foot and interstitial NO levels in the
probed foot during baseline conditions
and local heating to 44°C. No significant
difference in baseline blood flow among
groups was observed before or after exer-
cise, and DE subjects alone demonstrated
significantly enhanced baseline blood
flow (P  0.05) after exercise. No group
differences in blood flow were noted for
IRP or cold pressor responses (data not
shown). Maximal NO levels during local
heating did not differ significantly among
groups at either time.
Figure 1 demonstrates the response
to local heating after an acute bout of
maximal exercise; CE subjects had signif-
icantly higher blood flow than DS sub-
jects alone during the final minutes of
heating (P  0.05). As shown in Table 3,
no subject group experienced a signifi-
cant change in maximal blood flow with
local heating when comparing each
group’s pre- and postexercise values.
With groups combined by diabetes status,
however, control subjects exhibited a
higher maximal response to local heating
to 44°C than diabetic subjects (99.92 
7.57 vs. 74.67  6.83 perfusion units,
P  0.05) preexercise, with only a trend
toward higher heated flow after exercise
(P  0.07). Figure 2 additionally demon-
strates that the magnitude of increases in
blood flow in response to heating was
significantly lessened in both dia-
betic groups preexercise compared with
CE subjects, but only in DS subjects
postexercise.
Using multivariate correlational anal-
ysis, resting insulin resistance (HOMA
method) was found to correlate signifi-
cantly with both resting systolic (r 
0.37, P  0.01) and diastolic (r  0.31,
P  0.05) blood pressures. Both HbA1c
and fasting glucose levels were weakly in-
versely correlated with blood flow during
heating (but not during baseline condi-
tions) both before and after exercise (r 
0.32 for each, P  0.05).
CONCLUSIONS — The current study
examined dorsal foot skin blood flow be-
fore and after an acute bout of maximal
cycle ergometer exercise in diabetic and
control subjects. Baseline (nonstimu-
lated) blood flow was enhanced by prior
exercise in the more physically active di-
abetic subjects compared with control
subjects. With local heating to 44°C,
blood flow responsiveness was signifi-
cantly lower in both diabetic groups
compared with active control subjects
preexercise, but only less in sedentary in-
dividuals with diabetes after maximal
exercise.
During rest and exercise, the regula-
tion of microvascular blood flow to the
skin is undeniably complex and multifac-
eted. Although 75% of the blood flow re-
sponse to heating is regulated by small
C-fiber nociceptors (4), potent local vaso-
dilator compounds such as NO, prostacy-
clin, and bradykinin can also increase
capillary blood flow (1,3), whereas angio-
tensin II, endothelin, and norepinephrine
can cause vasoconstriction (2,3). Blood
flow may be shunted away from the skin
in the diabetic state because of the loss of
neural control over arteriovenous shunts
(5–7). In the forearm skin of type 2 dia-
betic subjects, significant C-fiber impair-
ment along with an attenuated NO-
mediated skin vasodilation has been
previously shown (8).
In the present study, baseline (non-
stimulated) dorsal foot blood flow before
exercise was not significantly different in
any subject group, but basal flow was sig-
nificantly enhanced after exercise in DE
subjects. This hyperemic baseline blood
flow response to prior maximal exercise,
not previously demonstrated in a diabetic
population and not evident in control
subjects, was interestingly heightened
by chronic exercise participation, even
though this group was not highly trained
compared with control subjects; we can
only speculate that even greater changes
would be present if active subjects had a
higher VO2peak relative to sedentary sub-
jects. These data conflict with previous
findings of blood flow decrements in a
diabetic population during resting condi-
tions (6,8), but they concur with our pre-
vious findings of enhanced cutaneous
blood flow under certain flow conditions
Table 2—Peak responses to exercise
CE CS DE DS
VO2 (m  kg
1  min1) 25.0  2.4 22.2  1.5 24.7  2.6 19.9  1.0
RPE 18.2  0.6 17.9  0.5 17.4  0.5 17.0  0.6
RER 0.98  0.02 1.02  0.03 0.98  0.01 1.03  0.02
HR (bpm) 154.6  5.2 155.6  3.8 150.7  4.9 141.9  6.3
Lactate (mmol/l) 4.4  0.5 4.4  0.4 3.8  0.3 3.9  0.3
SBP (mmHg) 180  6 184  5 190  5 198  6
DBP (mmHg) 90  2 92  2 93  2 97  3
Data are means  SE. DBP, diastolic blood pressure; HR, heart rate; RER, respiratory exchange ratio; RPE,
rating of perceived exertion; SBP, systolic blood pressure.
Table 3—Cutaneal blood flow and NO in the foot dorsum




Preexercise 6.43  1.18 6.67  0.84 6.92  0.70 9.32  2.05
Postexercise 8.81  2.42 8.17  1.15 14.08  2.92* 12.18  3.02
Local heat (44°C)
Preexercise 108.54  17.67 91.29  9.05 75.20  6.35† 74.96  6.41†
Postexercise 114.27  13.37 89.99  9.08 88.30  16.78 70.90  9.71‡
Nitric Oxide (nmol/l)
Local heat (44°C)
Preexercise 149.52  22.20 128.87  23.84 152.83  17.08 160.09  17.08
Postexercise 106.24  15.07 126.81  29.00 133.49  16.74 137.08  16.88
All data are means  SE. *P  0.05 vs. preexercise value; †P  0.05 DE and DS combined vs. CE and CS
combined; ‡P  0.05 vs. CE during same condition.
Colberg and Associates
DIABETES CARE, VOLUME 26, NUMBER 6, JUNE 2003 1885
in diabetic individuals who are chronic
exercisers (14).
Furthermore, local warming of the
skin to 42°C over 20–40 min has been
shown to cause maximal vasodilation
(22), and our current findings support
our previous discovery of a lower baseline
blood flow response to local heating in
sedentary diabetic subjects (14). After
maximal exercise is performed, cutane-
ous blood flow appears to also be regu-
lated differently in diabetic subjects than
active control subjects; both diabetic
groups exhibited a blunted responsive-
ness to local heat preexercise, which per-
sisted in the sedentary group only after
maximal exercise. Thus, these data sug-
gest that the presence of diabetes alone
negatively alters the blood flow response
to local heating to 44°C before and after
an acute bout of maximal exercise, but
that chronic activity may ameliorate this
effect.
Exercise training is known to enhance
thermoregulatory control, allowing
higher cutaneous flow at a given core
body temperature and, accordingly,
greater heat dissipation (23). Although
Kellogg et al. (24) demonstrated that NO
appears to play a role in cutaneous vaso-
dilation during local heating to 41°C,
whole-body heating did not increase NO
levels in the forearm skin, suggesting that
NO may serve only a permissive role dur-
ing and possibly after exercise (25). How-
ever, other studies have shown that
physically trained athletes have chroni-
cally increased basal NO metabolism (14)
as well as greater resting skin perfusion
(26).
In the present study, all subjects ex-
perienced a significant increase in basal
skin blood flow and NO in response to
local heating to 44°C, and as shown in
Fig. 1, blood flow continued to rise dur-
ing extended heating, whereas, although
not shown, NO levels actually leveled off
early in the same heating period. We pre-
viously suggested that the defective blood
flow response to local heating in diabetes
may be due to a diminished local effec-
tiveness of NO (14,15), but we were un-
able to substantiate this assertion with the
current data. Thus, the subjects’ equiva-
lent rise in NO suggests that blunted cu-
taneous blood flow in response to local
heating in diabetic subjects is likely me-
diated through non-NO mechanisms,
such as an altered sensitivity to local
neuropeptides (substance P, calcitonin
gene-related peptide, and others), com-
pounded by the concurrence of a seden-
tary lifestyle. However, without further
research, we cannot definitively rule out
the possibility that the bioavailability of
NO may have been negatively affected by
the production of superoxide from NO
synthase (NOS) mediated through pro-
tein kinase C (27). Additionally, Jack et al.
(28) recently reported that in diabetic
rats, endothelium-derived hyperpolariz-
ing factor (EDHF) may play a much larger
role than NO in endothelium-dependent
relaxation because diabetes itself mark-
edly reduced the contribution of EDHF in
the mesenteric vascular bed.
Finally, disordered neurogenic vaso-
dilation in diabetes may also be partly re-
lated to long-term hyperglycemia; in
poorly controlled streptozotocin-induced
diabetes in rats, it has been associated
with reduced NO synthesis and enhanced
quenching of available NO (12). Ad-
vanced glycation end products (AGEs),
also formed during hyperglycemic condi-
tions (29), can quench NO and directly
inhibit NOS activity (30). In a study by
Vallejo et al. (31), endothelial dysfunction
in diabetic rats was related to hyperglyce-
mia and elevated HbA1c (but not plasma
AGE levels) and to enhanced oxidative
stress caused by hyperglycemia. In the
current study, we observed an inverse re-
lationship between both fasting glucose
Figure 1—Dorsal foot blood flow after maximal exercise during local heating. *P  0.05 CE vs.
DS.
Figure 2—Responsiveness of dorsal foot blood flow to local heat before and after maximal exer-
cise. *P  0.05 vs. CE at the same time.
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or HbA1c and the maximal cutaneous
heated blood flow, but no relationship
with maximal NO release, again suggest-
ing that our findings are more likely at-
tributable to a deficiency of sensory
neuropeptides or EDHF, rather than the
quenching of NO (32,33). The role of in-
tracellular messengers or other non-NO
mechanisms should be the focus of future
studies because these are required for no-
ciceptor responses (34,35).
In summary, based on the current
data, both chronic activity and a prior
acute bout of maximal exercise may be
beneficial in preventing or reducing some
of the impairment in cutaneous blood
flow induced by diabetes itself. Regular
physical training may have the capacity to
offset some of its deleterious effects on
cutaneous blood flow under certain flow
conditions, and prior maximal exercise
may temporarily enhance basal cutaneous
blood flow and its responsiveness to local
warming. As such, exercise may still
prove to be an invaluable tool in the re-
tention of effective skin vasodilation and
prevention of foot ulcers.
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